New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 5, 2012
10:01 EDTCBS, HGG, TGT, NRG, MSG, ENB, BRO, WPZ, QCOM, MNKD, HES, EPB, ARO, STT, PRGO, MON, GCOOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Aeropostale (ARO) upgraded to Outperform from Market Perform at FBR Capital... Brown & Brown (BRO) upgraded to Buy from Neutral at Sterne Agee... CBS (CBS) upgraded to Overweight from Equal Weight at Barclays... Disney (DIS) upgraded to Buy from Hold at Argus... El Paso Pipeline (EPB) upgraded to Buy from Neutral at Goldman... Enbridge (ENB) upgraded to Buy from Neutral at Goldman... Genesco (GCO) upgraded to Buy from Hold at BB&T... Hess Corp. (HES) upgraded to Buy from Neutral at Global Hunter... Madison Square Garden (MSG) upgraded to Buy from Hold at Maxim... MannKind (MNKD) upgraded to Buy from Neutral at BofA/Merrill... Monsanto (MON) upgraded to Buy from Neutral at Monness Crespi... NRG Energy (NRG) upgraded to Buy from Neutral at Citigroup... Perrigo (PRGO) upgraded to Outperform from Market Perform at Barrington... Qualcomm (QCOM) upgraded to Buy from Neutral at Nomura... State Street (STT) upgraded to Overweight from Equal Weight at Evercore... Target (TGT) upgraded to Overweight from Neutral at JPMorgan... Williams Partners (WPZ) upgraded to Buy from Neutral at Goldman... hhgregg (HGG) upgraded to Above Average from Average at Caris.
News For ARO;BRO;CBS;EPB;ENB;GCO;HES;MSG;MON;MNKD;NRG;PRGO;QCOM;TGT;STT;WPZ;HGG From The Last 14 Days
Check below for free stories on ARO;BRO;CBS;EPB;ENB;GCO;HES;MSG;MON;MNKD;NRG;PRGO;QCOM;TGT;STT;WPZ;HGG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
April 14, 2014
11:09 EDTCBSOptions with increasing implied volatility: HZNP VJET YOKU CTRX CBS
10:02 EDTENBOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:53 EDTTGTTarget breach sparks retail push to upgrade card technology, Bloomberg says
Subscribe for More Information
06:50 EDTQCOMChecks show Apple not developing basebands, says Deutsche Bank
Deutsche Bank says that despite recent press reports, its industry checks show that Apple (AAPL) is not developing its own baseband chipset. Deutsche believes Apple likely seeking better integration with existing baseband chipsets or possibly developing its own internal WiFi chipset. The firm thinks Qualcomm's (QCOM) long term prospects remain intact and it reiterates a Buy rating on the stock with an $86 price target.
06:00 EDTENBEnbridge downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information
05:54 EDTMNKDStocks with implied volatility below IV index mean; QCOR MNKD
Stocks with implied volatility below IV index mean; Questcor (QCOR) 44, MannKind (MNKD) 83 according to iVolatility.
April 11, 2014
12:42 EDTQCOMOn The Fly: Analyst Initiation Summary
ASML (ASML) initiated with a Cautious at ISI Group... Analog Devices (ADI) initiated with a Buy at ISI Group... Applied Materials (AMAT) initiated with a Strong Buy at ISI Group... Aruba Networks (ARUN) initiated with a Buy at SunTrust... Broadcom (BRCM) initiated with a Neutral at ISI Group... CSX (CSX) initiated with an Outperform at Macquarie... Cisco (CSCO) initiated with a Buy at SunTrust... F5 Networks (FFIV) initiated with a Neutral at SunTrust... Genesee & Wyoming (GWR) initiated with a Neutral at Macquarie... Intel (INTC) initiated with a Neutral at ISI Group... Juniper (JNPR) initiated with a Buy at SunTrust... KLA-Tencor (KLAC) initiated with a Neutral at ISI Group... Lam Research (LRCX) initiated with a Strong Buy at ISI Group... Linear Technology (LLTC) initiated with a Cautious at ISI Group... Maxim Integrated (MXIM) initiated with a Neutral at ISI Group... Micron (MU) initiated with a Strong Buy at ISI Group... NVIDIA (NVDA) initiated with a Neutral at ISI Group... NXP Semiconductors (NXPI) initiated with a Strong Buy at ISI Group... Qualcomm (QCOM) initiated with a Strong Buy at ISI Group... Riverbed (RVBD) initiated with a Neutral at SunTrust... SanDisk (SNDK) initiated with a Neutral at ISI Group... Teradyne (TER) initiated with a Buy at ISI Group... Texas Instruments (TXN) initiated with a Neutral at ISI Group... Trulia (TRLA) initiated with a Neutral at Susquehanna... Union Pacific (UNP) initiated with a Neutral at Macquarie... Zillow (Z) initiated with a Positive at Susquehanna... Flamel Technologies (FLML) initiated with a Buy at Roth Capital... Parker Drilling (PKD) initiated with an Accumulate at Tudor Pickering.
10:59 EDTCBSOptions with increasing implied volatility: EXPE PBI CROX CBS ADSK
Subscribe for More Information
10:49 EDTEPBOptions with decreasing implied volatility: STZ EPB FDO YONG
10:46 EDTMNKDOptions with decreasing implied volatility: MNKD QCOR NQ WWE BBBY
10:19 EDTQCOMQualcomm, Ericsson recommended by RBC Capital
Subscribe for More Information
09:09 EDTQCOMQualcomm Ericsson recommended for near-term at RBC Capital
Subscribe for More Information
09:04 EDTAROAeropostale price target lowered to $5 from $7.50 at BofA/Merrill
Subscribe for More Information
06:04 EDTMNKDStocks with implied volatility below IV index mean; QCOR MNKD
Subscribe for More Information
April 10, 2014
16:11 EDTQCOMQualcomm initiated with a Strong Buy at ISI Group
Target $90.
12:29 EDTMNKDMannKind retreats after potential rival starts IPO process
Shares of drug maker MannKind (MNKD) are falling after a potential competitor, Dance Biopharm, sought to launch an initial public offering. WHAT'S NEW: Dance Biopharm filed papers with the SEC to raise $75M through an IPO last night. Like Mannkind, Dance has developed an inhaled insulin product that is supposed to treat diabetes. Dance's lead product, Dance 501, is designed to deliver liquid insulin through a small, handheld electronic inhaler, Dance stated in its IPO application. The company plans to launch a Phase III trial of the product in early 2015 and eventually seek regulatory approval of the product in the EU, U.S., and China. MannKind's AFREZZA, which is designed to deliver insulin through an inhaler, is currently under review for approval by the FDA. PRICE ACTION: In early afternoon trading, MannKind sank 30c, or 4.3%, to $6.70.
12:03 EDTCBSCBS says Stephen Colbert to be next 'Late Show' host
Subscribe for More Information
11:15 EDTEPBOptions with decreasing implied volatility: YONG STZ BBBY FDO EPB
11:03 EDTMNKDOptions with decreasing implied volatility: MNKD QCOR MU KMX
06:59 EDTEPBEl Paso Pipeline initiated with a Neutral at UBS
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use